Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 26, 2023

Panitumumab Plus Modified FOLFOX or Panitumumab Plus Fluorouracil and Leucovorin as Initial Treatment for Elderly Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation
J. Clin. Oncol 2023 Aug 03;[EPub Ahead of Print], S Lonardi, C Rasola, R Lobefaro, D Rossini, V Formica, M Scartozzi, GL Frassineti, G Boscolo, S Cinieri, S Di Donato, N Pella, F Bergamo, A Raimondi, E Arnoldi, L Antonuzzo, C Granetto, F Zustovich, M Ronzoni, S Leo, F Morano, F Loupakis, F Buggin, V Zagonel, M Fassan, C Cremolini, L Boni, F Pietrantonio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading